PREVENT Toxicology and Pharmacology Testing (PREVENT TOX)
Ended Master IDIQ Awarded
- Federal agency
-
National Institutes of Health
- Awardees
- 5
- Task orders
- 11
- Obligated
- $9,820,557
Vehicle facts
- Opportunity
-
- N01CN4500945 Solicitation number
- Agency
-
- National Institutes of Health Department of Health and Human Services
- Combined task order value
-
- $9,820,557 Current, with exercised options
- $9,898,430 Potential, with all options
- Last date to order 100% complete
- Shared ceiling
- $9,000,000.00 Less than its task orders have obligated
IDV award and task order details come from SAM.gov/FPDS.
About this vehicle
The National Institutes of Health awarded this Master IDIQ for preclinical toxicology and pharmacology testing supporting the PREVENT Cancer Program on September 22, 2015, with a shared ceiling of $9 million and a final ordering deadline of September 24, 2018—now closed for more than seven years.
This vehicle is no longer active. The ordering period ended in September 2018, and the most recent task order was awarded in September 2018. The vehicle obligated $9.8 million against a combined task-order potential value of $9.9 million, representing 99 percent utilization. All 11 awarded task orders funded National Cancer Institute preclinical studies for candidate cancer prevention agents across formulation development, toxicology, and pharmacology work supporting transition to clinical trials. Representative work included preclinical evaluation of lipid-based drug delivery systems, aerosol formulation development, vaccine candidate assessment, and toxicology studies for topical and systemic preventive compounds. Award dates clustered heavily in late 2015 and mid-2016, with ordering momentum declining sharply thereafter (six orders in 2015, two in 2016, one in 2017, and two in 2018).
IIT Research Institute captured the largest share, holding five orders totaling $5.7 million in combined potential value. University of Illinois and Lovelace Biomedical and Environmental Research Institute also received awards; the remaining primes (Southern Research Institute and SRI International) held single, low-value orders. All awards were unrestricted, with no set-aside designations used. Task-order values ranged from under $3,000 for orientation meetings to $2.3 million for substantive preclinical work, with most substantive work orders ranging from $1.2 million to $2.3 million and employing either firm-fixed-price or cost-plus-fixed-fee pricing. All customer demand originated from the National Cancer Institute; no other federal agencies placed orders under this vehicle.
This vehicle offers no current pursuit opportunity. Firms already positioned as standing awardees may retain residual value if rework or option exercises are available, but the vehicle's closed ordering period and nearly complete obligational status eliminate it as a new-work growth avenue.
Description
Preclinical PREVENT Cancer Program- Toxicology and Pharmacology Testing
IDV awards
Latest task orders
Show all 11
Top awardees by obligations
| Rank | Awardee | Obligated | Share |
|---|---|---|---|
| 1 | IIT Research Institute | $5,600,159 | 57% |
| 2 | University Of Illinois | $2,273,213 | 23% |
| 3 | University Of Illinois | $1,934,379 | 20% |
| 4 | Lovelace Biomedical And Environmental Research Institute, Inc. | $7,578 | <1% |
| 5 | Sri International | $2,879 | <1% |
| 6 | Southern Research Institute | $2,349 | <1% |
Top funding agencies by obligations
| Rank | Funding agency | Obligated | Share |
|---|---|---|---|
| 1 | Department of Health and Human Services | $9,820,557 | 100% |
Obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2026 | -$96 |
| FY2024 | $201,815 |
| FY2023 | $388,547 |
| FY2022 | -$517,014 |
| FY2021 | $872,995 |
| FY2020 | -$112,553 |
| FY2019 | $57,028 |
| FY2018 | $2,443,975 |
| FY2017 | $2,771,655 |
| FY2016 | $2,371,791 |
| FY2015 | $1,342,415 |
Show all 11
Quick answers
What is the PREVENT TOX contract vehicle?
PREVENT Toxicology and Pharmacology Testing (PREVENT TOX) is an indefinite delivery, indefinite quantity (IDIQ) contract vehicle run by National Institutes of Health (Department of Health and Human Services), awarded on September 22, 2015.
Which companies hold PREVENT TOX?
5 companies hold PREVENT TOX's IDV awards, one each. The latest went to Southern Research Institute on September 25, 2015. The awardees whose task orders obligated the most are IIT Research Institute, University Of Illinois and University Of Illinois.
How much has been spent through PREVENT TOX?
11 task orders have been placed under PREVENT TOX, obligating $9,820,557.
What is the shared ceiling of PREVENT TOX?
The shared ceiling listed for PREVENT TOX, $9,000,000, is less than its task orders have obligated.
Which agencies use PREVENT TOX the most?
The departments whose task orders under PREVENT TOX obligated the most are Department of Health and Human Services ($9,820,557).
On GovTribe
See this vehicle's full record
- Every IDV award and task order
- Funding by agency, awardee, NAICS and set-aside
- Teaming partners on this vehicle
- Ask GovTribe AI about this vehicle